ARTICLE
|
doi:10.20944/preprints202410.0490.v1
Subject:
Clinical Medicine,
Medicine And Pharmacology
Keywords:
Hereditary angioedema; HAE; Healthcare resource; C1 inhibitor; bradykinin; lanadelumab; long-term prophylaxis; LTP; bradykinin-mediated angioedema
Online: 8 October 2024 (03:12:35 CEST)